Voyta J C, Via D P, Kinnunen P K, Sparrow J T, Gotto A M, Smith L C
J Biol Chem. 1985 Jan 25;260(2):893-8.
Ten murine monoclonal antibodies have been produced that are specific for bovine milk lipoprotein lipase. One monoclonal antibody, bLPL-mAb-7, inhibited completely the apolipoprotein C-II (apo-C-II)-dependent enzymic hydrolysis of trioleoylglycerol in a phospholipid-stabilized emulsion, but had no effect on the hydrolysis of the water-soluble substrate p-nitro-phenylacetate. Four times more bLPL-mAb-7 was required to achieve 50% inactivation of lipoprotein lipase activity when the enzyme was preincubated with excess apo-C-II. Disruption of the binding of a dansyl-labeled apo-C-II peptide to lipoprotein lipase by bLPL-mAb-7 was demonstrated by resonance energy transfer, both in the presence and absence of lipid. This antibody thus appears to recognize the apo-C-II binding site of lipoprotein lipase. In addition, bLPL-mAb-7 also inhibited the lipoprotein lipase activity of human post-heparin plasma.
已制备出十种针对牛乳脂蛋白脂肪酶的鼠单克隆抗体。其中一种单克隆抗体bLPL-mAb-7在磷脂稳定的乳液中能完全抑制载脂蛋白C-II(apo-C-II)依赖性的三油酰甘油酶促水解,但对水溶性底物对硝基苯乙酸的水解没有影响。当酶与过量的apo-C-II预孵育时,需要四倍量的bLPL-mAb-7才能使脂蛋白脂肪酶活性失活50%。通过共振能量转移证明,无论有无脂质存在,bLPL-mAb-7都能破坏丹磺酰标记的apo-C-II肽与脂蛋白脂肪酶的结合。因此,这种抗体似乎识别脂蛋白脂肪酶的apo-C-II结合位点。此外,bLPL-mAb-7还抑制人肝素后血浆中的脂蛋白脂肪酶活性。